Disposition of 4660 shares by Serge Saxonov of 10X Genomics at 43.9959 subject to Rule 16b-3
| 1KJ Stock | EUR 12.61 0.07 0.56% |
Roughly 56% of 10X GENOMICS's investor base is looking to short. The analysis of current outlook of investing in 10X GENOMICS DL suggests that many traders are alarmed regarding 10X GENOMICS's prospects. The current market sentiment, together with 10X GENOMICS's historical and current headlines, can help investors time the market. In addition, many technical investors use 10X GENOMICS DL stock news signals to limit their universe of possible portfolio assets.
10X GENOMICS stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of 10X daily returns and investor perception about the current price of 10X GENOMICS DL as well as its diversification or hedging effects on your existing portfolios.
10X |
Filed transaction by 10X Genomics Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
10X GENOMICS Fundamental Analysis
We analyze 10X GENOMICS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 10X GENOMICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 10X GENOMICS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
10X GENOMICS is rated below average in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
10X GENOMICS DL Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 10X GENOMICS stock to make a market-neutral strategy. Peer analysis of 10X GENOMICS could also be used in its relative valuation, which is a method of valuing 10X GENOMICS by comparing valuation metrics with similar companies.
Peers
10X GENOMICS Related Equities
| 4LL | Teladoc | 3.92 | ||||
| 9EH | Evolent Health | 3.88 | ||||
| 2HE | Healthequity | 1.69 | ||||
| COPA | COMPUGROUP MEDSPADR | 0.97 | ||||
| 1KJ | 10X GENOMICS | 0.56 | ||||
| COP | CompuGroup Medical | 0.28 | ||||
| 3CM | RLX TECH | 0.54 | ||||
| COP | Compugroup Medical | 0.64 | ||||
| VEE | Veeva Systems | 2.16 | ||||
| 1XZ | Ping An | 2.60 |
Complementary Tools for 10X Stock analysis
When running 10X GENOMICS's price analysis, check to measure 10X GENOMICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X GENOMICS is operating at the current time. Most of 10X GENOMICS's value examination focuses on studying past and present price action to predict the probability of 10X GENOMICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X GENOMICS's price. Additionally, you may evaluate how the addition of 10X GENOMICS to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |